NICOLE MONROIG: Open Payments
NPI 1205208063 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,675 in 79 payments from 15 companies in 2025. Trend: 2023 $1,493 · 2024 $1,950 · 2025 $1,675
Food & beverage: $1,659Education: $16
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $363 |
| ABBVIE INC. | 17 | $352 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $231 |
| Lilly USA, LLC | 7 | $162 |
| Madrigal Pharmaceuticals | 5 | $129 |
| PFIZER INC. | 5 | $100 |
| Aimmune Therapeutics, Inc. | 2 | $63 |
| Novo Nordisk Inc | 3 | $60 |
| Braintree Laboratories, Inc. | 2 | $49 |
| Intercept Pharmaceuticals, Inc. | 2 | $43 |
Products named: TREMFYA, RINVOQ, OMVOH, REZDIFFRA, ENTYVIO, LINZESS, EOHILIA, VELSIPITY.
Industry payments across FL — which companies pay providers there.
